Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia | MicrobiomeTrials← Back to trialsNCT07277387
Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-09Est. Completion: 2028-12
Enrollment target: 350 participants Locations- Hospital Universitari Vall d'Hebron, Barcelona, Barcelona, Spain
- Complejo Asistencial Universitario de Salamanca, Salamanca, Salamanca, Spain
- Hospital Universitario Virgen Macarena, Seville, Sevilla, Spain
Other microbiome trials you might be interested in
Advanced Solid Tumors
This is a multicenter, open-label, dose-escalation, dose-exploration and dose-expansion study to evaluate the safety, to…
Birmingham, United StatesEst. completion Oct 26, 2021
PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer
Leflunomide in patients with PTEN-Altered advanced solid tumors or HER2 negative breast cancer. Phase 1A objectives are …
New York, United StatesEst. completion Jul 2027